drugset / Trial / NCT00274001

Quality of Life and Changes in Metabolism of Lipids and Glucose After Switching to a Nevirapine-based Regimen in HIV+ Patients

NCT00274001

Phase 4 Completed 158 enrolled Boehringer Ingelheim
RandomizedParallel-groupOpen-labelDiagnostic

Summary

The purpose of this trial is to compare the effect of switching to nevirapine (Viramune®)-containing regimen on quality of life of patients with fat abnormalities and virological control whilst receiving a PI-based regimen.

Timeline

Start
2001-09
Primary completion
2004-03
Completion
2004-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Nevirapine Small molecule 200 mg Oral